EPIPHASIC Trademark

Trademark Overview

On Tuesday, August 6, 2013, a trademark application was filed for EPIPHASIC with the United States Patent and Trademark Office. The USPTO has given the EPIPHASIC trademark a serial number of 86030165. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, June 9, 2022. This trademark is owned by Avidas Pharmaceuticals LLC. The EPIPHASIC trademark is filed in the Pharmaceutical Products category with the following description:

A proprietary dermatological delivery system in the form of pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate the topical and transdermal delivery of a wide range of pharmaceuticals
epiphasic

General Information

Serial Number86030165
Word MarkEPIPHASIC
Filing DateTuesday, August 6, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, June 9, 2022
Registration Number4760880
Registration DateTuesday, June 23, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements

Goods and ServicesA proprietary dermatological delivery system in the form of pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate the topical and transdermal delivery of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 14, 2013
Primary Code005
First Use Anywhere DateWednesday, March 4, 2015
First Use In Commerce DateWednesday, March 4, 2015

Trademark Owner History

Party NameAvidas Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDoylestown, PA 18901
Party NameAvidas Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDoylestown, PA 18901
Party NameAvidas Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDoylestown, PA 18901

Trademark Events

Event DateEvent Description
Friday, August 9, 2013NEW APPLICATION ENTERED
Wednesday, August 14, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 28, 2013ASSIGNED TO EXAMINER
Saturday, September 28, 2013NON-FINAL ACTION WRITTEN
Saturday, September 28, 2013NON-FINAL ACTION E-MAILED
Saturday, September 28, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 29, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 19, 2013ASSIGNED TO LIE
Tuesday, November 19, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, December 1, 2013WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, December 16, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, December 28, 2013PRIORITY ACTION WRITTEN
Saturday, December 28, 2013PRIORITY ACTION E-MAILED
Saturday, December 28, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, June 27, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 27, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 28, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 30, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, March 29, 2015TEAS STATEMENT OF USE RECEIVED
Saturday, May 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 29, 2015USE AMENDMENT FILED
Saturday, May 2, 2015STATEMENT OF USE PROCESSING COMPLETE
Saturday, May 16, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 19, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 23, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 21, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, June 9, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 9, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 9, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, June 23, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, December 14, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

epiphasic delivery topical facilitate transdermal compounds wide pharmaceuticals range consisting drug